AstraZeneca is trading at £12,270.00, up 3.14%, on October 14, 2026, as healthcare stocks rose after investors responded to UnitedHealth’s stronger-than-expected Q3 earnings and raised profit outlook.
- Broad U.S. indices were lower, so the move does not appear to reflect a general market rally.
- Nordea upgraded AstraZeneca to Buy from Sell on October 13; reporting does not establish the upgrade as the direct cause of this session’s rise.